Ads
related to: olaparib- What Is LYNPARZA?
Learn More About How LYNPARZA
Works And If It's Right For You.
- Side Effects
Learn More About Potential Side
Effects And Safety Information.
- Discover MyLYNPARZA
A Support Program Developed To
Provide Patient Education.
- View FAQs
Find Answers To Frequently
Asked Questions.
- What Is LYNPARZA?
Search results
Life-extending prostate cancer drug rejected for NHS
Press Association News via AOL· 2 years agoA drug which can extend the lives of some men with prostate cancer will not be approved for use on the NHS. In final guidance which rubber-stamps an...
Cancer patients to receive ‘life-changing’ AstraZeneca drug through NHS
The Independent UK via AOL· 1 year agoOlaparib, manufactured by pharmaceutical company AstraZeneca, could benefit hundreds who suffer from...
FDA Casts Doubt on Merck/AstraZeneca's Cancer Drug for Prostate Cancer Ahead of Adcomm Meeting
Benzinga via Yahoo Finance· 1 year agoThe FDA's Oncologic Drugs Advisory Committee will be meeting tomorrow, Friday, 28 April, to discuss...
AstraZeneca (AZN) Gets EU Nod to Expanded Use of 2 Cancer Drugs
Zacks via Yahoo Finance· 1 year agoAstraZeneca PLC AZN, along with partner Merck MRK, announced that the European Commission (EC) has...
AstraZeneca-Merck's Prostate Cancer Drug Under FDA Priority Review For Expanded Use
Benzinga via Yahoo Finance· 2 years agoThe FDA has accepted AstraZeneca Plc’s (NASDAQ: AZN) supplemental marketing application for Lynparza...
Back-To-Back Three Japanese Approvals For AstraZeneca's Rare Disease Treatments
Benzinga via Yahoo Finance· 2 years agoThe Japan regulatory authority has approved AstraZeneca Plc (NASDAQ: AZN) and Merck Co Inc's (NYSE:...
Europe Approves AstraZeneca's Two Combo Therapies For Prostate, Bile Duct Cancer Settings
Benzinga via Yahoo Finance· 1 year agoThe European Commission has approved AstraZeneca Plc (NASDAQ: AZN) and Merck & Co Inc's (NYSE: MRK)...
Tango Therapeutics Shuts Early-Stage Cancer Study Due To Liver Toxicity
Benzinga via Yahoo Finance· 2 weeks agoOn Thursday, Tango Therapeutics Inc. (NASDAQ:TNGX) announced that it will discontinue the...
European Medicines Agency's Advisory Committee Backs Approval Of AstraZeneca's Three Cancer Drugs
Benzinga via Yahoo Finance· 2 years agoThe Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has...
AstraZeneca' Cancer Drug Combo Meets Goal In Late-Stage Ovarian Cancer Study
Benzinga via Yahoo Finance· 1 year agoAstraZeneca Plc (NASDAQ: AZN) announced topline data from a planned interim analysis of the DUO-O...
Ads
related to: olaparib
